Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
⏸️ Investing
These 3 shares just hit 52-week highs: Is it too late to invest?
⏸️ Investing
S&P/ASX 200 open Thursday: 7 shares to watch
⏸️ Investing
Why the Nanosonics Ltd share price is going gangbusters today
⏸️ Investing
How I'm making money from the plunging Australian Dollar (A$) in 2017
⏸️ Investing
Why the Cochlear Limited share price is heading to a record high today
⏸️ Investing
When it comes to the stock market, here's where the really big money is made
⏸️ Investing
2 ASX shares for a low Australian Dollar (A$)
⏸️ Investing
Revealed: This could be the best growth share on the ASX
⏸️ Investing
Mayne Pharma Group Ltd shares plunge as it warns of tougher drugs pricing environment
⏸️ Investing
5 ways to profit from Australia's ageing population
⏸️ Investing
My Top 5 Investing Predictions for the Rest of 2017
⏸️ Investing
Should you buy these 3 shares to bet on a lower Aussie Dollar?
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
